{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:03:20Z","timestamp":1794279800327,"version":"4.9.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL128620"],"award-info":[{"award-number":["R01HL128620"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007534"],"award-info":[{"award-number":["T32HL007534"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F32HL176086"],"award-info":[{"award-number":["F32HL176086"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL128620"],"award-info":[{"award-number":["R01HL128620"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007534"],"award-info":[{"award-number":["T32HL007534"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F32HL176086"],"award-info":[{"award-number":["F32HL176086"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Medications, including inhaled bronchodilators, are essential for effective management of chronic obstructive pulmonary disease (COPD) and to improve clinical outcomes. However, medications are a major driver of out-of-pocket costs for individuals with COPD. The impact of cost of medications on clinical outcomes in COPD has not been studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the association between difficulty affording medications and COPD morbidity, psychological well-being, and medication adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Individuals with a physician\u2019s diagnosis of COPD who were prescribed at least one daily maintenance medication were recruited from centers in the Mid-Atlantic area and followed for 12 months as part of the Medication Adherence Research in COPD (MARC) cohort. Patient-reported COPD outcomes, measures of psychological well-being, exacerbation data, and difficulty affording medications were assessed at 6-month intervals. Medication adherence was measured during the 12-month period using electronic monitors. The association between difficulty affording medications at baseline and outcomes at 12 months was evaluated using multivariable regression models. A fixed effects regression model was conducted to evaluate how changes in difficulty affording medications are associated with outcomes over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 249 participants with completed baseline assessments, a total of 44 (18%) participants reported delaying refilling medications because of cost at baseline. Over the course of the 12-month period, 68 (27%) participants reported delaying refilling medications at any time point because of cost. After adjusting for baseline covariates, no associations between difficulty affording medications at baseline and outcomes at 12 months were observed. In the fixed effects model, changes in difficulty affording medications were associated with worse COPD health status, dyspnea, and health-related quality of life; increased symptoms of anxiety and depression; and lower objectively measured medication adherence but not occurrence of exacerbations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this multicenter cohort of individuals with physician-diagnosed COPD, we found an association between changes in self-reported difficulty affording medications and increased patient-reported respiratory morbidity, increased anxiety and depression symptoms, and decreased objectively measured medication adherence over time, but no association with exacerbations. These findings suggest that cost of COPD-specific treatments is an important and potentially modifiable social determinant of health for individuals with COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202410-1020oc","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:44:06Z","timestamp":1739983446000},"page":"984-991","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":3,"title":["Association Between Difficulty Affording Medications and Outcomes in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8453-8671","authenticated-orcid":false,"given":"Sonal G.","family":"Mallya","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Psoter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Case","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Vest","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Christiana Care Health System, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Putcha","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.","family":"Hansel","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-8343","authenticated-orcid":false,"given":"Michelle N.","family":"Eakin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2026012203123512000_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.2009.113662","article-title":"Adherence to inhaled therapy, mortality and hospital admission in COPD","volume":"64","author":"Vestbo","year":"2009","journal-title":"Thorax"},{"key":"2026012203123512000_bib2","first-page":"92","article-title":"Impact of nonadherence to inhaled corticosteroid\/LABA therapy on COPD exacerbation rates and healthcare costs in a commercially insured US population","volume":"10","author":"Davis","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"2026012203123512000_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"2026012203123512000_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40261-017-0612-2","article-title":"Adherence to inhaled medications and its effect on healthcare utilization and costs among high-grade chronic obstructive pulmonary disease patients","volume":"38","author":"Kim","year":"2018","journal-title":"Clin Drug Investig"},{"key":"2026012203123512000_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjopharm.2012.04.002","article-title":"Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population","volume":"10","author":"Simoni-Wastila","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"2026012203123512000_bib6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","article-title":"Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD","volume":"107","author":"M\u00e4kel\u00e4","year":"2013","journal-title":"Respir Med"},{"key":"2026012203123512000_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rmed.2013.08.044","article-title":"Clinical and economic impact of non-adherence in COPD: a systematic review","volume":"108","author":"van Boven","year":"2014","journal-title":"Respir Med"},{"key":"2026012203123512000_bib8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jamainternmed.2015.1665","article-title":"The impact of the US Food and Drug Administration chlorofluorocarbon ban on out-of-pocket costs and use of albuterol inhalers among individuals with asthma","volume":"175","author":"Jena","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026012203123512000_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1164\/rccm.201810-1865ST","article-title":"Improving the affordability of prescription medications for people with chronic respiratory disease. An Official American Thoracic Society policy statement","volume":"198","author":"Patel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203123512000_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40258-023-00814-8","article-title":"Direct medical costs of COPD in the USA: an analysis of the Medical Expenditure Panel Survey 2017-2018","volume":"21","author":"Shah","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"key":"2026012203123512000_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12890-022-01892-5","article-title":"Understanding barriers to and strategies for medication adherence in COPD: a qualitative study","volume":"22","author":"O\u2019Toole","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026012203123512000_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.09-3031","article-title":"Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease","volume":"138","author":"Castaldi","year":"2010","journal-title":"Chest"},{"key":"2026012203123512000_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201905-400OC","article-title":"High-deductible health plans and healthcare access, use, and financial strain in those with chronic obstructive pulmonary disease","volume":"17","author":"Gaffney","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203123512000_bib14","first-page":"474","article-title":"Self-reported COPD medication use and adherence in the COPD Foundation Patient-Powered Registry Network","volume":"8","author":"Pasquale","year":"2021","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026012203123512000_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/09612033231186113","article-title":"Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: the Michigan Lupus Epidemiology & Surveillance program","volume":"32","author":"Minhas","year":"2023","journal-title":"Lupus"},{"key":"2026012203123512000_bib16","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.mayocp.2021.02.026","article-title":"Cost-related nonadherence to medications among US adults with chronic liver diseases","volume":"96","author":"Lago-Hernandez","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026012203123512000_bib17","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.5888\/pcd17.200244","article-title":"Cost-related nonadherence and mortality in patients with chronic disease: a multiyear investigation, National Health Interview Survey, 2000-2014","volume":"17","author":"Van Alsten","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"2026012203123512000_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.mlr.0000129352.36733.cc","article-title":"The health effects of restricting prescription medication use because of cost","volume":"42","author":"Heisler","year":"2004","journal-title":"Med Care"},{"key":"2026012203123512000_bib19","first-page":"A4984","article-title":"Cost-related nonadherence in the Medication Adherence Research in COPD (MARC) study [abstract]","volume":"209","author":"Mallya","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203123512000_bib20","doi-asserted-by":"crossref","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012203123512000_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","article-title":"Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease","volume":"12","author":"Kripalani","year":"2009","journal-title":"Value Health"},{"key":"2026012203123512000_bib22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/jocn.15976","article-title":"Multidimensional factors affecting medication adherence among patients with chronic obstructive pulmonary disease","volume":"31","author":"Aldan","year":"2022","journal-title":"J Clin Nurs"},{"key":"2026012203123512000_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1513\/AnnalsATS.202211-975OC","article-title":"Predictors of patient-reported and pharmacy refill measures of maintenance inhaler adherence in veterans with chronic obstructive pulmonary disease","volume":"21","author":"Pattock","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203123512000_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012203123512000_bib25","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/COPD.S82408","article-title":"Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease","volume":"10","author":"Perez","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203123512000_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St George\u2019s Respiratory Questionnaire","volume":"85 Suppl B","author":"Jones","year":"1991","journal-title":"Respir Med"},{"key":"2026012203123512000_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2026012203123512000_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale: an updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"2026012203123512000_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ije\/dyt221","article-title":"Fixed effects analysis of repeated measures data","volume":"43","author":"Gunasekara","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2026012203123512000_bib30","doi-asserted-by":"crossref","first-page":"973858","DOI":"10.1155\/2014\/973858","article-title":"Accuracy of the Hospital Anxiety and Depression Scale for identifying depression in chronic obstructive pulmonary disease patients","volume":"2014","author":"Nowak","year":"2014","journal-title":"Pulm Med"},{"key":"2026012203123512000_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1479972316634604","article-title":"Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease","volume":"13","author":"Phan","year":"2016","journal-title":"Chron Respir Dis"},{"key":"2026012203123512000_bib32","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2105\/AJPH.94.10.1782","article-title":"Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk","volume":"94","author":"Piette","year":"2004","journal-title":"Am J Public Health"},{"key":"2026012203123512000_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12889-024-18333-z","article-title":"Cost-related medication nonadherence in adults with COPD in the United States 2013-2020","volume":"24","author":"Wen","year":"2024","journal-title":"BMC Public Health"},{"key":"2026012203123512000_bib34","doi-asserted-by":"crossref","first-page":"e221167","DOI":"10.1001\/jamahealthforum.2022.1167","article-title":"Out-of-pocket costs and prescription filling behavior of commercially insured individuals with chronic obstructive pulmonary disease","volume":"3","author":"Patel","year":"2022","journal-title":"JAMA Health Forum"},{"key":"2026012203123512000_bib35","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamainternmed.2024.3499","article-title":"Reduced cost sharing and medication management services for COPD: a randomized clinical trial","volume":"184","author":"Agarwal","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026012203123512000_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"2026012203123512000_bib37","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2026012203123512000_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.socscimed.2013.05.009","article-title":"The high price of debt: household financial debt and its impact on mental and physical health","volume":"91","author":"Sweet","year":"2013","journal-title":"Soc Sci Med"},{"key":"2026012203123512000_bib39","doi-asserted-by":"crossref","first-page":"e005180","DOI":"10.1161\/CIRCOUTCOMES.118.005180","article-title":"Association between financial burden, quality of life, and mental health among those with atherosclerotic cardiovascular disease in the united states","volume":"11","author":"Annapureddy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012203123512000_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpainsymman.2018.12.003","article-title":"Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review","volume":"57","author":"Chan","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026012203123512000_bib41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JOP.2013.001322","article-title":"Impact of financial burden of cancer on survivors\u2019 quality of life","volume":"10","author":"Fenn","year":"2014","journal-title":"J Oncol Pract"},{"key":"2026012203123512000_bib42","doi-asserted-by":"crossref","first-page":"103037","DOI":"10.1016\/j.msard.2021.103037","article-title":"Longitudinal changes of financial hardship in patients with multiple sclerosis","volume":"53","author":"Sadigh","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"2026012203123512000_bib43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"key":"2026012203123512000_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2022.07.017","article-title":"Comprehensive score for financial toxicity and health-related quality of life in patients with cancer and survivors: a systematic review and meta-analysis","volume":"26","author":"Pangestu","year":"2023","journal-title":"Value Health"},{"key":"2026012203123512000_bib45","doi-asserted-by":"crossref","first-page":"e0306620","DOI":"10.1371\/journal.pone.0306620","article-title":"Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"2026012203123512000_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamainternmed.2016.9386","article-title":"Medicare part D plans\u2019 coverage and cost-sharing for acute rescue and preventive inhalers for chronic obstructive pulmonary disease","volume":"177","author":"Tseng","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026012203123512000_bib47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S2213-2600(24)00012-2","article-title":"US Senate committee investigates asthma inhaler prices","volume":"12","author":"Furlow","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026012203123512000_bib48","first-page":"1","article-title":"Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients","volume":"7","author":"Make","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203123512000_bib49","article-title":"Out-of-pocket prescription drug savings for Medicare beneficiaries with asthma and COPD under the Inflation Reduction Act","author":"Mein","year":"2024","journal-title":"J Gen Intern Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/7\/984\/66007481\/annalsats_22_7_984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/7\/984\/66007481\/annalsats_22_7_984.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:13:28Z","timestamp":1769069608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/22\/7\/984\/8381917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,1]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202410-1020oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2024-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}